Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

Viktoria Warneke,Hans-Michael Behrens,Christine Böger,T. Becker,F. Lordick,Matthias P. Ebert,Christoph Röcken

Her2/neu testing in gastric cancer: evaluating the risk of sampling errors

2013

Viktoria Warneke
Hans-Michael Behrens
Christine Böger
T. Becker
F. Lordick
Matthias P. Ebert
Christoph Röcken

Background We evaluated the risk of sampling errors in specimens of biopsy size, which may be caused by heterogeneous overexpression of Her2/neu in gastric cancer (GC).

Keywords:

Cancer
Tissue Array Analysis
Pathology
Sampling error
Biopsy
HER2/neu
Medicine
Adenocarcinoma
Stomach
Immunohistochemistry
Gastrectomy
Trastuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

106

Citations